Conditions: Idiopathic Short Stature
Keywords: growth hormone
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 70
Healthy volunteers: no

Brief summary:
Growth hormone therapy will improve the height of idiopathic short statured children. DA-3002(Recombinant Human Growth hormone)treated group for 26 weeks, will be compared to non-treatment group in efficacy and safety.

Detailed description:

Arms:
arm 1: 1.11 IU(0.37mg)/kg bodyweight of DA-3002 per week given by subcutaneous injections (six or seven times per week) arm 2: Height be measured with no treatment

Interventions: intervention 1: DA-3002
Intervention descriptions: intervention 1: None

Protocol document: